Sponsor Dossier
GlaxoSmithKline
Sponsor Dossier for GlaxoSmithKline. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AIRZATE ACCUHALER
- Brand: ANORO
- Brand: AREXVY
- Brand: ARNUITY ELLIPTA
- Brand: AVAMYS
- Brand: AVODART
- Brand: AXOTIDE
- Brand: BACTROBAN
- Device (sponsor): Medicine chamber spacer
- Device (sponsor): Curette Dermal
- Device (sponsor): Skin-coring punch, single-use
About
GlaxoSmithKline is an Australian Private Company with ABN 47 100 162 481, registered in Victoria. The company is Active and operates under the trading names GSK Melbourne, Stiefel (a GSK Company), Allen and Hanburys, and GlaxoSmithKline Consumer Healthcare.
Portfolio
GlaxoSmithKline maintains 48 brands on the ARTG, of which 46 are indexable. The portfolio includes 45 brands with Product Information on file, 25 brands with PBAC outcome records, and 12 brands with AusPARs on record. Six brands have at least one PBS-listed item.
Therapeutic focus The portfolio spans ten therapeutic areas:
— Infectious Disease: 18 brands — Respiratory: 16 brands — Oncology: 3 brands — Haematology: 2 brands — Immunology: 2 brands — Urology: 2 brands — Dermatology: 2 brands — Reproductive Health: 1 brand — Gastroenterology: 1 brand — Cardiology: 1 brand
PBS footprint
Six brands in the GlaxoSmithKline portfolio hold at least one PBS-listed item, with the portfolio's latest PBS schedule date being 1 May 2026.
Regulatory activity
The most recent PBAC outcome for GlaxoSmithKline was dated 1 December 2025, with 25 brands holding PBAC outcomes on record. The latest AusPAR was issued on 12 November 2025, with 12 brands holding AusPARs on record.